IQVIA Holdings Inc.

243.44+0.6400+0.26%Vol 1.09M1Y Perf 75.32%
Jun 11th, 2021 16:03 DELAYED
BID233.40 ASK252.00
Open243.00 Previous Close242.80
Pre-Market- After-Market-
 - -  - -%
Target Price
250.36 
Analyst Rating
Strong Buy 1.26
Potential %
2.84 
Finscreener Ranking
★★     45.86
Insiders Trans % 3/6/12 mo.
-/100/-60 
Value Ranking
+     35.51
Insiders Value % 3/6/12 mo.
-/100/-59 
Growth Ranking
★★     47.82
Insiders Shares Cnt. % 3/6/12 mo.
-/100/-61 
Income Ranking
 —    -
Market Cap46.66B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
98.65 
Earnings Date
28th Jul 2021

Today's Price Range

240.48243.54

52W Range

133.18244.95

5 Year PE Ratio Range

16.00186.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
4.11%
1 Month
6.77%
3 Months
30.31%
6 Months
45.07%
1 Year
75.32%
3 Years
131.96%
5 Years
271.27%
10 Years
-

TickerPriceChg.Chg.%
IQV243.440.64000.26
AAPL127.351.24000.98
GOOG2 513.93-7.6700-0.30
MSFT257.890.65000.25
XOM62.17-0.5800-0.92
WFC45.680.59001.31
JNJ164.96-2.1200-1.27
FB331.26-1.2000-0.36
GE13.690.06000.44
JPM160.29-0.1100-0.07
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.10
0.68
2.11
2.30
Leverage Ratio 4.10
ProfitabilityValueIndustryS&P 500US Markets
33.70
7.80
18.60
4.00
3.61
RevenueValueIndustryS&P 500US Markets
12.01B
62.68
4.64
13.42
Earnings HistoryEstimateReportedSurprise %
Q01 20211.702.0520.59
Q04 20201.802.0011.11
Q03 20201.411.506.38
Q02 20200.911.0313.19
Q01 20201.351.5011.11
Q04 20191.591.50-5.66
Q03 20191.441.493.47
Q02 20191.381.390.72
Earnings Per EndEstimateRevision %Trend
6/2021 QR1.9213.61Positive
9/2021 QR1.895.00Positive
12/2021 FY8.1510.73Positive
12/2022 FY9.378.45Positive
Next Report Date28th Jul 2021
Estimated EPS Next Report1.92
Estimates Count6
EPS Growth Next 5 Years %12.80
Volume Overview
Volume1.09M
Shares Outstanding191.66M
Trades Count19.83K
Dollar Volume267.30M
Avg. Volume958.05K
Avg. Weekly Volume988.04K
Avg. Monthly Volume1.01M
Avg. Quarterly Volume976.69K

IQVIA Holdings Inc. (NYSE: IQV) stock closed at 243.44 per share at the end of the most recent trading day (a 0.26% change compared to the prior day closing price) with a volume of 1.09M shares and market capitalization of 46.66B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 70000 people. IQVIA Holdings Inc. CEO is Ari Bousbib.

The one-year performance of IQVIA Holdings Inc. stock is 75.32%, while year-to-date (YTD) performance is 35.87%. IQV stock has a five-year performance of 271.27%. Its 52-week range is between 133.18 and 244.95, which gives IQV stock a 52-week price range ratio of 98.65%

IQVIA Holdings Inc. currently has a PE ratio of 111.40, a price-to-book (PB) ratio of 7.53, a price-to-sale (PS) ratio of 3.72, a price to cashflow ratio of 17.10, a PEG ratio of 2.32, a ROA of 1.67%, a ROC of 4.02% and a ROE of 6.90%. The company’s profit margin is 3.61%, its EBITDA margin is 18.60%, and its revenue ttm is $12.01 Billion , which makes it $62.68 revenue per share.

Of the last four earnings reports from IQVIA Holdings Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.92 for the next earnings report. IQVIA Holdings Inc.’s next earnings report date is 28th Jul 2021.

The consensus rating of Wall Street analysts for IQVIA Holdings Inc. is Strong Buy (1.26), with a target price of $250.36, which is +2.84% compared to the current price. The earnings rating for IQVIA Holdings Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

IQVIA Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

IQVIA Holdings Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.93, ATR14 : 4.47, CCI20 : 108.51, Chaikin Money Flow : -0.02, MACD : 3.58, Money Flow Index : 48.58, ROC : 0.54, RSI : 65.54, STOCH (14,3) : 89.21, STOCH RSI : 1.00, UO : 59.67, Williams %R : -10.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of IQVIA Holdings Inc. in the last 12-months were: Ari Bousbib (Sold 230 400 shares of value $37 870 848 ), John G. Danhakl (Buy at a value of $11 227 654), Ronald A. Rittenmeyer (Sold 50 382 shares of value $8 770 771 ), Ronald E. Bruehlman (Buy at a value of $1 599 400), W. Richard Staub (Option Excercise at a value of $2 955 127), W. Richard Staub (Sold 20 367 shares of value $3 265 332 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
14 (82.35 %)
14 (82.35 %)
13 (81.25 %)
Moderate Buy
1 (5.88 %)
1 (5.88 %)
1 (6.25 %)
Hold
2 (11.76 %)
2 (11.76 %)
2 (12.50 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.26
Strong Buy
1.26
Strong Buy
1.28

IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

CEO: Ari Bousbib

Telephone: +1 919 998-2000

Address: 4820 Emperor Boulevard, Durham 27703, NC, US

Number of employees: 70 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

57%43%

Bearish Bullish

57%43%

News

Stocktwits